Ophthalmology

New gene therapy for vision loss proven safe in humans

In a small and preliminary clinical trial, Johns Hopkins researchers and their collaborators have shown that an experimental gene therapy that uses viruses to introduce a therapeutic gene into the eye is safe and that it ...

Ophthalmology

Mixed results for stem cell treatments of AMD

(HealthDay)—Stem cells may offer new hope for patients with age-related macular degeneration, but that promise can come with some risks, according to research published in the March 17 issue of the New England Journal of ...

Genetics

Genome surgery with CRISPR-Cas9 to prevent blindness

It is estimated that almost one in every ten people over 65 has some signs of age-related macular degeneration (AMD), and its prevalence is likely to increase as a consequence of the aging population. AMD is a form of blindness, ...

page 17 from 39